CIK: 0001306923 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value ($000): $1,721,541 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ABIOMED INC | 1,884,384 | $242,294 | 14.1% | $29.48 | — | COM | 003654100 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 1,763,458 | $208,229 | 12.1% | $85.99 | +39.7% | COM | 91307C102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,790,899 | $165,694 | 9.6% | $76.38 | +23.3% | COM | 09061G101 |
| — | CLOVIS ONCOLOGY INC | 3,804,088 | $137,137 | 8.0% | $53.87 | — | COM | 189464100 |
| — | AMAG PHARMACEUTICALS INC | 3,326,720 | $81,538 | 4.7% | $29.94 | — | COM | 00163U106 |
| INSM | INSMED INC | 5,091,298 | $73,926 | 4.3% | $14.63 | -14.4% | COM PAR $.01 | 457669307 |
| — | CEMPRA INC | 2,844,483 | $68,836 | 4.0% | $22.71 | — | COM | 15130J109 |
| — | ALEXION PHARMACEUTICALS INC | 561,700 | $68,831 | 4.0% | $119.05 | — | COM | 015351109 |
| VNDA | VANDA PHARMACEUTICALS INC | 4,110,708 | $68,402 | 4.0% | $8.54 | +57.7% | COM | 921659108 |
| — | WRIGHT MED GROUP N V | 2,440,493 | $59,865 | 3.5% | $23.40 | — | ORD SHS 0.03 PAR | N96617118 |
| PRTA | PROTHENA CORP PLC | 934,455 | $56,039 | 3.3% | $29.22 | +83.6% | SHS | G72800108 |
| — | ZELTIQ AESTHETICS INC | 1,414,563 | $55,479 | 3.2% | $27.05 | — | COM | 98933Q108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,481,930 | $47,140 | 2.7% | $29.67 | +14.3% | COM | 004225108 |
| FOLD | AMICUS THERAPEUTICS INC | 5,685,388 | $42,072 | 2.4% | $6.12 | +10.3% | COM | 03152W109 |
| — | SAGE THERAPEUTICS INC | 902,051 | $41,539 | 2.4% | $38.68 | — | COM | 78667J108 |
| — | ARIAD PHARMACEUTICALS INC | 2,587,617 | $35,424 | 2.1% | $7.02 | — | COM | 04033A100 |
| — | CELGENE CORP | 292,700 | $30,596 | 1.8% | $97.51 | — | COM | 151020104 |
| STAA | STAAR SURGICAL CO | 3,244,610 | $30,499 | 1.8% | $7.82 | +2.7% | COM PAR $0.01 | 852312305 |
| — | KARYOPHARM THERAPEUTICS INC | 3,085,849 | $30,025 | 1.7% | $20.75 | — | COM | 48576U106 |
| — | EPIZYME INC | 2,814,540 | $27,695 | 1.6% | $13.55 | — | COM | 29428V104 |
| GILD | GILEAD SCIENCES INC | 318,400 | $25,192 | 1.5% | $63.20 | -8.6% | COM | 375558103 |
| — | SHIRE PLC | 123,200 | $23,884 | 1.4% | $221.47 | — | SPONSORED ADR | 82481R106 |
| — | MOMENTA PHARMACEUTICALS INC | 1,650,876 | $19,299 | 1.1% | $14.05 | — | COM | 60877T100 |
| — | ENDO INTL PLC | 945,330 | $19,048 | 1.1% | $78.87 | — | SHS | G30401106 |
| — | RIGEL PHARMACEUTICALS INC | 5,186,088 | $19,033 | 1.1% | $3.39 | — | COM NEW | 766559603 |
| EXAS | EXACT SCIENCES CORP | 396,976 | $7,372 | 0.4% | $12.83 | +37.3% | COM | 30063P105 |
| — | ACELRX PHARMACEUTICALS INC | 1,634,608 | $6,359 | 0.4% | $5.54 | — | COM | 00444T100 |
| — | AIMMUNE THERAPEUTICS INC | 379,727 | $5,696 | 0.3% | $23.85 | — | COM | 00900T107 |
| — | SUNESIS PHARMACEUTICALS INC | 1,162,473 | $5,080 | 0.3% | $4.37 | — | COM PAR | 867328700 |
| — | ALIMERA SCIENCES INC | 3,013,793 | $4,491 | 0.3% | $4.88 | — | COM | 016259103 |
| ALGN | ALIGN TECHNOLOGY INC | 37,457 | $3,512 | 0.2% | $59.75 | +51.4% | COM | 016255101 |
| — | IDERA PHARMACEUTICALS INC | 1,257,748 | $3,220 | 0.2% | $3.70 | — | COM NEW | 45168K306 |
| — | DICERNA PHARMACEUTICALS INC | 267,890 | $1,575 | 0.1% | $9.72 | — | COM | 253031108 |
| — | HISTOGENICS CORP | 454,545 | $1,459 | 0.1% | $11.00 | — | COM | 43358V109 |
| — | INTREXON CORP | 47,100 | $1,320 | 0.1% | $28.82 | — | COM | 46122T102 |
| CYTK | CYTOKINETICS INC | 123,686 | $1,135 | 0.1% | $6.71 | +55.5% | COM NEW | 23282W605 |
| — | SOPHIRIS BIO INC | 247,000 | $768 | 0.0% | $2.60 | — | COM NEW | 83578Q209 |
| — | ALCOBRA LTD | 272,788 | $674 | 0.0% | $5.98 | — | SHS | M2239P109 |
| — | OREXIGEN THERAPEUTICS INC | 167,302 | $555 | 0.0% | $3.32 | — | COM NEW | 686164302 |
| — | ZOGENIX INC | 29,500 | $337 | 0.0% | $13.36 | — | COM NEW | 98978L204 |
| QURE | UNIQURE NV | 20,453 | $156 | 0.0% | $26.34 | -69.9% | SHS | N90064101 |
| — | MARINUS PHARMACEUTICALS INC | 63,517 | $116 | 0.0% | $7.84 | — | COM | 56854Q101 |